Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies
- PMID: 38631667
- DOI: 10.1016/j.lfs.2024.122629
Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies
Abstract
Ferroptosis is a novel type of controlled cell death resulting from an imbalance between oxidative harm and protective mechanisms, demonstrating significant potential in combating cancer. It differs from other forms of cell death, such as apoptosis and necrosis. Molecular therapeutics have hard time playing the long-acting role of ferroptosis induction due to their limited water solubility, low cell targeting capacity, and quick metabolism in vivo. To this end, small molecule inducers based on biological factors have long been used as strategy to induce cell death. Research into ferroptosis and advancements in nanotechnology have led to the discovery that nanomaterials are superior to biological medications in triggering ferroptosis. Nanomaterials derived from iron can enhance ferroptosis induction by directly releasing large quantities of iron and increasing cell ROS levels. Moreover, utilizing nanomaterials to promote programmed cell death minimizes the probability of unfavorable effects induced by mutations in cancer-associated genes such as RAS and TP53. Taken together, this review summarizes the molecular mechanisms involved in ferroptosis along with the classification of ferroptosis induction. It also emphasized the importance of cell organelles in the control of ferroptosis in cancer therapy. The nanomaterials that trigger ferroptosis are categorized and explained. Iron-based and noniron-based nanomaterials with their characterization at the molecular and cellular levels have been explored, which will be useful for inducing ferroptosis that leads to reduced tumor growth. Within this framework, we offer a synopsis, which traverses the well-established mechanism of ferroptosis and offers practical suggestions for the design and therapeutic use of nanomaterials.
Keywords: Ferroptosis; Iron-based nanocomposites; Molecular dynamics; Nanomaterials; Non-Iron-based nanocomposites.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The potential application of nanomaterials for ferroptosis-based cancer therapy.Biomed Mater. 2021 Jun 11;16(4). doi: 10.1088/1748-605X/ac058a. Biomed Mater. 2021. PMID: 34038885 Review.
-
Engineering Iron-Based Nanomaterials for Breast Cancer Therapy Associated with Ferroptosis.Nanomedicine (Lond). 2024 Mar;19(6):537-555. doi: 10.2217/nnm-2023-0270. Epub 2024 Jan 31. Nanomedicine (Lond). 2024. PMID: 38293902 Review.
-
Advances in Manganese-based nanomaterials for cancer therapy via regulating Non-Ferrous ferroptosis.Int J Pharm. 2025 Jan 25;669:125101. doi: 10.1016/j.ijpharm.2024.125101. Epub 2024 Dec 18. Int J Pharm. 2025. PMID: 39706379 Review.
-
Versatile Nanomaterials That Interfere with Ferroptosis in the Tumor Microenvironment.Int J Nanomedicine. 2025 Feb 25;20:2461-2473. doi: 10.2147/IJN.S508767. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40027870 Free PMC article. Review.
-
Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment.Anticancer Agents Med Chem. 2024;24(8):571-589. doi: 10.2174/0118715206278427231215111526. Anticancer Agents Med Chem. 2024. PMID: 38275050 Review.
Cited by
-
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches.Drug Des Devel Ther. 2024 Jun 21;18:2485-2529. doi: 10.2147/DDDT.S472178. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38919962 Free PMC article. Review.
-
Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies.MedComm (2020). 2025 Feb 23;6(3):e70116. doi: 10.1002/mco2.70116. eCollection 2025 Mar. MedComm (2020). 2025. PMID: 39991627 Free PMC article. Review.
-
Demystifying the management of cancer through smart nano-biomedicine via regulation of reactive oxygen species.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):497-532. doi: 10.1007/s00210-024-03469-x. Epub 2024 Oct 31. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39480523 Review.
-
Ferroptosis and Metabolic Dysregulation: Emerging Chemical Targets in Cancer and Infection.Molecules. 2025 Jul 18;30(14):3020. doi: 10.3390/molecules30143020. Molecules. 2025. PMID: 40733290 Free PMC article. Review.
-
Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies.Cancer Biol Med. 2025 Jul 24;22(7):726-46. doi: 10.20892/j.issn.2095-3941.2025.0115. Cancer Biol Med. 2025. PMID: 40708274 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous